The present disclosure pertains to medical devices, and methods for manufacturing and/or using medical devices. More particularly, the present disclosure pertains to leadless cardiac devices and methods, such as leadless pacing devices and methods, and delivery devices and methods for such leadless devices.
A wide variety of medical devices have been developed for medical use, for example, cardiac use. Some of these devices include catheters, leads, pacemakers, and the like, and delivery devices and/or systems used for delivering such devices. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices, delivery system, and methods, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices and delivery devices as well as alternative methods for manufacturing and using medical devices and delivery devices.
This disclosure provides design, material, manufacturing method, and use alternatives for medical devices, including delivery devices. An example medical device includes a delivery device for delivering an implantable leadless pacing device having an outer peripheral surface. The delivery device may include a proximal section including a distal end, and a distal holding section extending distally of a distal end of the proximal section. The distal holding section defines a cavity therein for receiving the implantable leadless pacing device, and may be configured to apply a holding force to the implantable leadless pacing device. In some cases, the distal holding section may be configured to apply a compressive force to the outer peripheral surface of the leadless pacing device when the leadless pacing device is disposed in the cavity. In some embodiments, the distal holding section includes an annular wall having an inner surface defining the cavity, and wherein the inner surface presses circumferentially against the outer peripheral surface of the leadless pacing device when the leadless pacing device is disposed in the cavity. In some cases, the distal holding section comprises a heat shrink material that applies the compressive force to the outer peripheral surface of the leadless pacing device. In some cases, the distal holding section comprises a resilient material that applies the compressive force to the outer peripheral surface of the leadless pacing device, for example a resilient material that elastically deforms when the leadless pacing device is disposed in the cavity. In other cases, the distal holding section may include a material that plastically deforms when the leadless pacing device is disposed in the cavity.
In some embodiments, the cavity of the distal holding section comprises an inner diameter, and the inner diameter is the same as or less than an outer diameter of the leadless pacing device. For example, where the inner diameter is less than an outer diameter of the leadless pacing device, and the holding section may be expandable such that the inner diameter expands when the leadless pacing device is disposed in the cavity.
In some situations, the cavity of the distal holding section comprises a distal portion that has an inner diameter that is less than the outer diameter of the leadless pacing device, and the distal portion may be expandable such that the inner diameter of the distal portion will expand as the leadless pacing device is delivered there through. In some situations, the cavity of the distal holding section includes a proximal section having a first inner diameter that is the same as the an outer diameter of the leadless pacing device, and a distal section that has a second inner diameter that is less than the outer diameter of the leadless pacing device.
In some embodiments, the distal holding section includes an annular wall having an inner surface defining the cavity, the inner surface configured to engage the outer peripheral surface of the leadless pacing device while being free of any gap between the inner surface of the annular wall and outer surface of the leadless pacing device.
In some embodiments, the compressive force applied by the distal holding section to the outer peripheral surface of the leadless pacing device provides circumferential frictional engagement between the distal holding section and the leadless pacing device. In some embodiments, the distal holding section slidably receives the implantable leadless pacing device, which in some cases is a non-expandable, implantable leadless pacing device, for example, an implantable leadless pacing device including a non-expandable housing.
Some embodiments relate to an implantable leadless pacing device system including a delivery device including elements or configurations set forth above, or disclosed herein; and an implantable leadless pacing device disposed within the cavity of the distal holding section of the delivery device.
Some other embodiments relate to methods for delivering an implantable leadless pacing device. The methods may include delivering the implantable leadless pacing device into the heart of a patient using a delivery system or delivery device including elements or configurations set forth above, or disclosed herein.
The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present disclosure. The Figures, and Detailed Description, which follow, more particularly exemplify some of these embodiments.
The disclosure may be more completely understood in consideration of the following detailed description in connection with the accompanying drawings, in which:
While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment described may include one or more particular features, structures, and/or characteristics. However, such recitations do not necessarily mean that all embodiments include the particular features, structures, and/or characteristics. Additionally, when particular features, structures, and/or characteristics are described in connection with one embodiment, it should be understood that such features, structures, and/or characteristics may also be used connection with other embodiments whether or not explicitly described unless clearly stated to the contrary.
The following detailed description should be read with reference to the drawings in which similar structures in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
Cardiac pacemakers provide electrical stimulation to heart tissue to cause the heart to contract and thus pump blood through the vascular system. Conventional pacemakers typically include an electrical lead that extends from a pulse generator implanted subcutaneously or sub-muscularly to an electrode positioned adjacent the inside or outside wall of the cardiac chamber. As an alternative to conventional pacemakers, self-contained or leadless cardiac pacemakers have been proposed. Leadless cardiac pacemakers are small capsules typically fixed to an intracardiac implant site in a cardiac chamber. The small capsule typically includes bipolar pacing/sensing electrodes, a power source (e.g. a battery), and associated electrical circuitry for controlling the pacing/sensing electrodes, and thus provide electrical stimulation to heart tissue and/or sense a physiological condition. It can be readily appreciated that the implantation of a leadless pacing device within a beating heart could become dislodged as the heart functions. Accordingly, it may be desirable for a leadless pacing device to include one or more anchoring mechanism or member to help securing the pacing device to the heart.
The implantable device 10 may include a pulse generator (e.g., electrical circuitry) and a power source (e.g., a battery) within the housing 12 to provide electrical signals to the electrodes 20, 22 and thus control the pacing/sensing electrodes 20, 22. Electrical communication between pulse generator and the electrodes 20, 22 may provide electrical stimulation to heart tissue and/or sense a physiological condition.
The implantable device 10 may include a fixation mechanism 24 proximate the distal end 16 of the housing 12 configured to attach the implantable device 10 to a tissue wall of the heart H, or otherwise anchor the implantable device 10 to the anatomy of the patient. As shown in
The implantable device 10 may include a docking member 30 proximate the proximal end 14 of the housing 12 configured to facilitate delivery and/or retrieval of the implantable device 10. For example, the docking member 30 may extend from the proximal end 14 of the housing 12 along a longitudinal axis of the housing 12. The docking member 30 may include a head portion 32 and a neck portion 34 extending between the housing 12 and the head portion 32. The head portion 32 may be an enlarged portion relative to the neck portion 34. For example, the head portion 32 may have a radial dimension from the longitudinal axis of the implantable device 10 which is greater than a radial dimension of the neck portion from the longitudinal axis of the implantable device 10. The docking member 30 may be configured to facilitate delivery of the implantable device 10 to the intracardiac site and/or retrieval of the implantable device 10 from the intracardiac site.
One aspect of the current disclosure relates to the delivery device and/or system used, for example, to deliver device 10 to a suitable location within the anatomy (e.g., the heart). As may be appreciated, the delivery device may need to be navigated through relatively tortuous anatomy to deliver the device 10 to a suitable location. For instance, in some embodiments, the delivery device may be advanced through the vasculature to a target region. In some example cases the device may be advanced through a femoral vein, into the inferior vena cava, into the right atrium, through the tricuspid valve, and into the right ventricle. The target region for the delivery of the device 10 may be a portion of the right ventricle, for example, a portion of the right ventricle near the apex of the heart. It may be desirable to provide the delivery system with certain features that may allow for easier or better control for navigation or delivery purposes, and securement of the device 10 with the delivery device or system until deployment is desired. For example, delivery devices with a smaller delivery profile may be desired. It may also be desired to provide for delivery devices that securely hold or maintain the device 10 with, in, or on the delivery device during navigation or positioning of the device 10 to or at the target cite prior to deployment of the device 10, and then allows deployment of the device 10 when desired.
The distal holding section 146 may be configured to receive the implantable device 10 therein. For example, the holding section 146 may define a cavity 148 for slidably receiving the implantable device 10, and may include a distal opening 150 for slidable insertion and/or extraction of the implantable device 10 into and/or out of the cavity 148. As will be discussed in more detail below, the distal holding section 146 may be configured to secure or hold the implantable device 10 therein until deployment is desired.
A push member 160 may be disposed (e.g., slidably disposed) within a lumen of the delivery device 100, for example through a lumen of the proximal section 140 of shaft 142. The push member 160 may be engaged by a user near the proximal end of the delivery device 100, and extend through a lumen in the delivery device 100, through the proximal section 140 and into the distal holding section 146. A distal portion 164 of the push member 160 may be capable of engaging the device 10, and the push member 160 may be used to “push” device 10 out from distal holding section 146 so as to deploy and anchor device 10 within a target region (e.g., a region of the heart such as the right ventricle).
As indicated above, the distal holding section 146 may be configured to secure or hold the implantable device 10 therein until deployment is desired. For example, referring to
In some embodiments, the distal holding section 146 may be configured to apply a compressive force to the outer peripheral surface 17 of the leadless pacing device 10 when the leadless pacing device is disposed in the cavity 148. This compressive force may act as a holding force to aid in selectively maintaining the implantable device 10 within the cavity 148. For example, in the embodiment shown, the distal holding section 146 may include an annular wall 147 having an inner surface 149 defining the cavity 148. The distal holding section 146 may be configured such that the inner surface 149 applies a compressive force against the outer peripheral surface 17 of the leadless pacing device 10 when the leadless pacing device is disposed in the cavity 148. For example, distal holding section 146 may include structure or materials that biases or predisposes at least a portion of the inner surface 149 to apply a compressive force against the outer surface 17. In some aspects, the inner surface 149 may be configured to grasp, grip, hug, squeeze, or clinch the outer peripheral surface 17 of the leadless pacing device 10. The compressive force may be circumferential about the housing 12 along at least a portion of the length of the housing 12. For example, in some cases, there is no gap or opening between the inner surface 149 and the outer peripheral surface 17 around the entire circumference of the leadless pacing device 10 along at least a portion of the length of the housing 12. In some cases, the compressive force may provide enhanced circumferential frictional engagement between the surfaces 149 and 17.
A number of ways are contemplated to generate such a holding force.
For example, in some embodiments, the distal holding section 146 may include or be made of a shrinkable material, such as a heat shrink material or the like. In some such embodiments, the leadless pacing device 10 may be disposed within the cavity 148, and heat or other activation mechanism may be applied to the shrink material such that at least a portion of the distal holding section 146 shrinks around at least a portion of the outer peripheral surface 17 of the leadless pacing device 10. As such, at least a portion of the inner surface 149 of the distal holding section 146 applies the compressive force to the outer peripheral surface 17 of the leadless pacing device.
In some embodiments, the distal holding section 146 may include or be made of a resilient or elastic material or structure that may apply a compressive force to the outer peripheral surface 17 of the leadless pacing device 10 when disposed therein. Such resilient or elastic material or structures may or may not be shrinkable materials. For example, distal holding section 146 may be made of resilient or elastic material or structure, and may be dimensioned such that in a relaxed state, the cavity 148 has an inner diameter that is the same as or smaller than an outer diameter of the leadless pacing device 10, for example the outer diameter of the housing 12 of the leadless pacing device 10. The leadless pacing device 10 is disposed within the cavity 148, thereby stretching or elastically deforming the distal holding section 146 to receive the leadless pacing device 10. Due to the dimensional differences, and the resilient or elastic properties of the distal holding section 146, a compressive force is applied to the outer peripheral surface 17 of the leadless pacing device 10. Some examples of such elastic material include elastic polymers, metals, or the like or combinations thereof. In a similar manner, some examples of structures that may be incorporated into the distal holding section 146 that may provide resilient or elastic properties thereto include an elastic coil, braid, or other similar structures.
In some other embodiments, the distal holding section 146 may include or be made of a non-resilient or plastically deformable material or structure that applies a holding force to the outer peripheral surface 17 of the leadless pacing device 10. Such non-resilient or plastically deformable material or structure may or may not be shrinkable materials. For example, distal holding section 146 made of non-resilient or plastically deformable material or structure, and may be dimensioned such that the cavity 148 has an inner diameter that is substantially the same as or less than the outer diameter of the leadless pacing device 10. When the leadless pacing device 10 is inserted into the cavity 148 of the distal holding section 146, the distal holding section may plastically deform tightly around the leadless pacing device 10 (in the case where cavity 148 has an inner diameter that less than the outer diameter of the leadless pacing device 10) or simply fit tightly around the leadless pacing device 10 (in the case where cavity 148 has an inner diameter that is substantially the same as the outer diameter of the leadless pacing device 10). The tight dimensional relationship between the leadless pacing device 10 and the distal holding section 146 may provide circumferential frictional engagement between the surfaces 149 and 17, in some cases without applying a compressive force. In some cases, the inner surface 149 of the distal holding section 146, the outer surface 17 of the leadless pacing device 10, or both may include structure, features, or a coating that provides for enhanced frictional engagement between the surfaces 149 and 17.
As can be appreciated, many of these configurations may provide for a delivery device 100 having a smaller or “lower” profile for deliverability purposes. For example, in cases where shrink material or elastic or resilient material are used for the distal holding section 146, all or portions of the holding section 146 can be engineered to have a smaller profile or outer diameter. In some cases, as can be seen in the figures, the distal portion of the holding section 146 (that may extend distally of the leadless pacing device 10 when it is disposed in the cavity) may have a reduced outer diameter. In addition, the tight fit and/or tolerance between the holding section 146 and the device 10 provides for a lower profile.
Referring back to
Moving now to
Finally,
The materials that can be used for the various components of the delivery devices, such as delivery device 100 (or other delivery devices disclosed herein) and the various members disclosed herein may include those commonly associated with medical devices. For simplicity purposes, the following discussion makes reference the delivery devices 100 and components of thereof. However, this is not intended to limit the devices and methods described herein, as the discussion may be applied to other similar delivery systems and/or components of delivery systems or devices disclosed herein.
The delivery device 100 or other components of delivery system may be made from a metal, metal alloy, polymer (some examples of which are disclosed below), a metal-polymer composite, ceramics, combinations thereof, and the like, or other suitable material. Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane (for example, Polyurethane 85A), polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), poly(styrene-b-isobutylene-b-styrene) (for example, SIBS and/or SIBS 50A), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments the polymer can be blended with a liquid crystal polymer (LCP). For example, the mixture can contain up to about 6 percent LCP.
Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys (e.g., UNS: N06625 such as INCONEL® 625, UNS: N06022 such as HASTELLOY® C-22®, UNS: N10276 such as HASTELLOY® C276®, other HASTELLOY® alloys, and the like), nickel-copper alloys (e.g., UNS: N04400 such as MONEL® 400, NICKELVAC® 400, NICORROS® 400, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nickel-molybdenum alloys (e.g., UNS: N10665 such as HASTELLOY® ALLOY B2®), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like); platinum enriched stainless steel; titanium; combinations thereof; and the like; or any other suitable material.
As alluded to herein, within the family of commercially available nickel-titanium or nitinol alloys, is a category designated “linear elastic” or “non-super-elastic” which, although may be similar in chemistry to conventional shape memory and super elastic varieties, may exhibit distinct and useful mechanical properties. Linear elastic and/or non-super-elastic nitinol may be distinguished from super elastic nitinol in that the linear elastic and/or non-super-elastic nitinol does not display a substantial “superelastic plateau” or “flag region” in its stress/strain curve like super elastic nitinol does. Instead, in the linear elastic and/or non-super-elastic nitinol, as recoverable strain increases, the stress continues to increase in a substantially linear, or a somewhat, but not necessarily entirely linear relationship until plastic deformation begins or at least in a relationship that is more linear that the super elastic plateau and/or flag region that may be seen with super elastic nitinol. Thus, for the purposes of this disclosure linear elastic and/or non-super-elastic nitinol may also be termed “substantially” linear elastic and/or non-super-elastic nitinol.
In some cases, linear elastic and/or non-super-elastic nitinol may also be distinguishable from super elastic nitinol in that linear elastic and/or non-super-elastic nitinol may accept up to about 2-5% strain while remaining substantially elastic (e.g., before plastically deforming) whereas super elastic nitinol may accept up to about 8% strain before plastically deforming. Both of these materials can be distinguished from other linear elastic materials such as stainless steel (that can also can be distinguished based on its composition), which may accept only about 0.2 to 0.44 percent strain before plastically deforming.
In some embodiments, the linear elastic and/or non-super-elastic nickel-titanium alloy is an alloy that does not show any martensite/austenite phase changes that are detectable by differential scanning calorimetry (DSC) and dynamic metal thermal analysis (DMTA) analysis over a large temperature range. For example, in some embodiments, there may be no martensite/austenite phase changes detectable by DSC and DMTA analysis in the range of about ˜60 degrees Celsius (° C.) to about 120° C. in the linear elastic and/or non-super-elastic nickel-titanium alloy. The mechanical bending properties of such material may therefore be generally inert to the effect of temperature over this very broad range of temperature. In some embodiments, the mechanical bending properties of the linear elastic and/or non-super-elastic nickel-titanium alloy at ambient or room temperature are substantially the same as the mechanical properties at body temperature, for example, in that they do not display a super-elastic plateau and/or flag region. In other words, across a broad temperature range, the linear elastic and/or non-super-elastic nickel-titanium alloy maintains its linear elastic and/or non-super-elastic characteristics and/or properties.
In some embodiments, the linear elastic and/or non-super-elastic nickel-titanium alloy may be in the range of about 50 to about 60 weight percent nickel, with the remainder being essentially titanium. In some embodiments, the composition is in the range of about 54 to about 57 weight percent nickel. One example of a suitable nickel-titanium alloy is FHP-NT alloy commercially available from Furukawa Techno Material Co. of Kanagawa, Japan. Some examples of nickel titanium alloys are disclosed in U.S. Pat. Nos. 5,238,004 and 6,508,803, which are incorporated herein by reference. Other suitable materials may include ULTANIUM™ (available from Neo-Metrics) and GUM METAL™ (available from Toyota). In some other embodiments, a superelastic alloy, for example a superelastic nitinol can be used to achieve desired properties.
In at least some embodiments, portions or all of the delivery device 100 or other components of delivery system may be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user of the delivery devices 100/100b/200/300/400 in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like. Additionally, other radiopaque marker bands and/or coils may also be incorporated into the design of the delivery device 100 to achieve the same result.
In some embodiments, a degree of Magnetic Resonance Imaging (MRI) compatibility is imparted into the delivery device 100. For example, delivery devices 100/100b/200/300/400, or portions or components thereof, may be made of a material that does not substantially distort the image and create substantial artifacts (i.e., gaps in the image). Certain ferromagnetic materials, for example, may not be suitable because they may create artifacts in an MRI image. The delivery device 100, or portions thereof, may also include and/or be made from a material that the MRI machine can image. Some materials that exhibit these characteristics include, for example, tungsten, cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nitinol, and the like, and others.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
This application claims the benefit of U.S. Provisional Application No. 61/866,898 filed Aug. 16, 2013, the complete disclosure of which is herein incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
721869 | Dunning | Mar 1903 | A |
3717151 | Collett | Feb 1973 | A |
3754555 | Schmitt | Aug 1973 | A |
3814104 | Irnich et al. | Jun 1974 | A |
3835864 | Rasor et al. | Sep 1974 | A |
3902501 | Citron et al. | Sep 1975 | A |
3943936 | Rasor | Mar 1976 | A |
3971364 | Fletcher et al. | Jul 1976 | A |
3976082 | Schmitt | Aug 1976 | A |
4103690 | Harris | Aug 1978 | A |
4112952 | Thomas et al. | Sep 1978 | A |
4269198 | Stokes | May 1981 | A |
4280512 | Karr | Jul 1981 | A |
4301815 | Doring | Nov 1981 | A |
4402328 | Doring | Sep 1983 | A |
4409994 | Doring | Oct 1983 | A |
4502492 | Bornzin | Mar 1985 | A |
4662382 | Sluetz et al. | May 1987 | A |
4898577 | Badger et al. | Feb 1990 | A |
4913164 | Greene et al. | Apr 1990 | A |
5003990 | Osypka | Apr 1991 | A |
5057114 | Wittich et al. | Oct 1991 | A |
5129749 | Sato | Jul 1992 | A |
5171233 | Amplatz et al. | Dec 1992 | A |
5193540 | Schulman et al. | Mar 1993 | A |
5257634 | Kroll | Nov 1993 | A |
5282845 | Bush et al. | Feb 1994 | A |
5300107 | Stokes et al. | Apr 1994 | A |
5318528 | Heaven et al. | Jun 1994 | A |
5336253 | Gordon et al. | Aug 1994 | A |
5405367 | Schulman et al. | Apr 1995 | A |
5405374 | Stein | Apr 1995 | A |
5411535 | Fujii et al. | May 1995 | A |
5425756 | Heil et al. | Jun 1995 | A |
5443492 | Stokes et al. | Aug 1995 | A |
5492119 | Abrams | Feb 1996 | A |
5522875 | Gates et al. | Jun 1996 | A |
5522876 | Rusink | Jun 1996 | A |
5545201 | Helland et al. | Aug 1996 | A |
5545206 | Carson | Aug 1996 | A |
5562723 | Rugland et al. | Oct 1996 | A |
5575814 | Giele et al. | Nov 1996 | A |
5578068 | Laske et al. | Nov 1996 | A |
5697936 | Shipko et al. | Dec 1997 | A |
5716390 | Li | Feb 1998 | A |
5716391 | Grandjean | Feb 1998 | A |
5755764 | Schroeppel | May 1998 | A |
5776178 | Pohndorf et al. | Jul 1998 | A |
5807399 | Laske et al. | Sep 1998 | A |
5837006 | Ocel et al. | Nov 1998 | A |
5837007 | Altman et al. | Nov 1998 | A |
5851226 | Skubitz et al. | Dec 1998 | A |
5871531 | Struble | Feb 1999 | A |
5908381 | Aznoian et al. | Jun 1999 | A |
5908447 | Schroeppel et al. | Jun 1999 | A |
6041258 | Cigaina et al. | Mar 2000 | A |
6055457 | Bonner | Apr 2000 | A |
6074401 | Gardnier et al. | Jun 2000 | A |
6078840 | Stokes | Jun 2000 | A |
6093177 | Javier et al. | Jul 2000 | A |
6129749 | Bartig et al. | Oct 2000 | A |
6132456 | Sommer et al. | Oct 2000 | A |
6181973 | Ceron et al. | Jan 2001 | B1 |
6188932 | Lindegren | Feb 2001 | B1 |
6240322 | Peterfeso et al. | May 2001 | B1 |
6251104 | Kesten et al. | Jun 2001 | B1 |
6290719 | Garberoglio | Sep 2001 | B1 |
6321124 | Cigaina | Nov 2001 | B1 |
6322548 | Payne et al. | Nov 2001 | B1 |
RE37463 | Altman | Dec 2001 | E |
6358256 | Reinhardt | Mar 2002 | B1 |
6363938 | Saadat et al. | Apr 2002 | B2 |
6381495 | Jenkins | Apr 2002 | B1 |
6381500 | Fischer, Sr. | Apr 2002 | B1 |
6408214 | Williams et al. | Jun 2002 | B1 |
6458145 | Ravenscroft et al. | Oct 2002 | B1 |
6477423 | Jenkins | Nov 2002 | B1 |
6500182 | Foster | Dec 2002 | B2 |
6510332 | Greenstein | Jan 2003 | B1 |
6510345 | Van Bentem | Jan 2003 | B1 |
6522915 | Ceballos et al. | Feb 2003 | B1 |
6572587 | Lerman et al. | Jun 2003 | B2 |
6582441 | He et al. | Jun 2003 | B1 |
6592581 | Bowe | Jul 2003 | B2 |
6623518 | Thompson et al. | Sep 2003 | B2 |
6626915 | Leveillee | Sep 2003 | B2 |
6638268 | Niazi | Oct 2003 | B2 |
6684109 | Osypka | Jan 2004 | B1 |
6711443 | Osypka | Mar 2004 | B2 |
6743240 | Smith et al. | Jun 2004 | B2 |
6755812 | Peterson et al. | Jun 2004 | B2 |
6909920 | Lokhoff et al. | Jun 2005 | B2 |
6944507 | Froberg et al. | Sep 2005 | B2 |
6953454 | Peterson et al. | Oct 2005 | B2 |
7027876 | Casavant et al. | Apr 2006 | B2 |
7082335 | Klein et al. | Jul 2006 | B2 |
7085606 | Flach et al. | Aug 2006 | B2 |
7092765 | Geske et al. | Aug 2006 | B2 |
7092766 | Salys et al. | Aug 2006 | B1 |
7120504 | Osypka | Oct 2006 | B2 |
7149587 | Wardle et al. | Dec 2006 | B2 |
7158838 | Seifert et al. | Jan 2007 | B2 |
7162310 | Doan | Jan 2007 | B2 |
7181288 | Rezai et al. | Feb 2007 | B1 |
7187982 | Seifert et al. | Mar 2007 | B2 |
7200437 | Nabutovsky et al. | Apr 2007 | B1 |
7212869 | Wahlstrom et al. | May 2007 | B2 |
7229415 | Schwartz | Jun 2007 | B2 |
7251532 | Hess et al. | Jul 2007 | B2 |
7289853 | Campbell et al. | Oct 2007 | B1 |
7313445 | McVenes et al. | Dec 2007 | B2 |
7326231 | Phillips et al. | Feb 2008 | B2 |
7328071 | Stehr et al. | Feb 2008 | B1 |
7383091 | Chitre et al. | Jun 2008 | B1 |
7450999 | Karicherla et al. | Nov 2008 | B1 |
7462184 | Worley et al. | Dec 2008 | B2 |
7463933 | Wahlstrom et al. | Dec 2008 | B2 |
7499758 | Cates et al. | Mar 2009 | B2 |
7509169 | Eigler et al. | Mar 2009 | B2 |
7515971 | Doan | Apr 2009 | B1 |
7532939 | Sommer et al. | May 2009 | B2 |
7558631 | Cowan et al. | Jul 2009 | B2 |
7634319 | Schneider et al. | Dec 2009 | B2 |
7647109 | Hastings et al. | Jan 2010 | B2 |
7657325 | Williams | Feb 2010 | B2 |
7678128 | Boyle et al. | Mar 2010 | B2 |
7717899 | Bowe et al. | May 2010 | B2 |
7731655 | Smith et al. | Jun 2010 | B2 |
7734343 | Ransbury et al. | Jun 2010 | B2 |
7740640 | Ginn | Jun 2010 | B2 |
7785264 | Hettrick et al. | Aug 2010 | B2 |
7799037 | He et al. | Sep 2010 | B1 |
7801624 | Flannery et al. | Sep 2010 | B1 |
7835801 | Sundararajan et al. | Nov 2010 | B1 |
7840281 | Kveen et al. | Nov 2010 | B2 |
7840283 | Bush et al. | Nov 2010 | B1 |
7860580 | Falk et al. | Dec 2010 | B2 |
7875049 | Eversull et al. | Jan 2011 | B2 |
7890186 | Wardle et al. | Feb 2011 | B2 |
7904179 | Rutten et al. | Mar 2011 | B2 |
7920928 | Yang et al. | Apr 2011 | B1 |
7993351 | Worley et al. | Aug 2011 | B2 |
8010209 | Jacobson | Aug 2011 | B2 |
8036757 | Worley | Oct 2011 | B2 |
8057486 | Hansen | Nov 2011 | B2 |
8082035 | Glukhovsky | Dec 2011 | B2 |
8103361 | Moser | Jan 2012 | B2 |
8108054 | Helland | Jan 2012 | B2 |
8142347 | Griego et al. | Mar 2012 | B2 |
8160722 | Rutten et al. | Apr 2012 | B2 |
8185213 | Kveen et al. | May 2012 | B2 |
8219213 | Sommer et al. | Jul 2012 | B2 |
8233994 | Sommer et al. | Jul 2012 | B2 |
8252019 | Fleming, III | Aug 2012 | B2 |
8295939 | Jacobson | Oct 2012 | B2 |
8313445 | Mishima et al. | Nov 2012 | B2 |
8352025 | Jacobson | Jan 2013 | B2 |
8352028 | Wenger | Jan 2013 | B2 |
8364277 | Glukhovsky | Jan 2013 | B2 |
8364280 | Marnfeldt et al. | Jan 2013 | B2 |
8406900 | Barlov et al. | Mar 2013 | B2 |
8406901 | Starkebaum et al. | Mar 2013 | B2 |
8428750 | Kolberg | Apr 2013 | B2 |
8452420 | Flach et al. | May 2013 | B2 |
8478431 | Griswold et al. | Jul 2013 | B2 |
8489189 | Tronnes | Jul 2013 | B2 |
8494650 | Glukhovsky et al. | Jul 2013 | B2 |
8504156 | Bonner et al. | Aug 2013 | B2 |
8518060 | Jelich et al. | Aug 2013 | B2 |
8527068 | Ostroff | Sep 2013 | B2 |
8532790 | Griswold | Sep 2013 | B2 |
8548605 | Ollivier | Oct 2013 | B2 |
8565897 | Regnier et al. | Oct 2013 | B2 |
8615310 | Khairkhahan et al. | Dec 2013 | B2 |
8634912 | Bornzin et al. | Jan 2014 | B2 |
8670842 | Bornzin et al. | Mar 2014 | B1 |
8721587 | Berthiaume et al. | May 2014 | B2 |
8727996 | Allan et al. | May 2014 | B2 |
8758365 | Bonner et al. | Jun 2014 | B2 |
20020077556 | Schwartz | Jun 2002 | A1 |
20030004537 | Boyle | Jan 2003 | A1 |
20040176797 | Opolski | Sep 2004 | A1 |
20050080430 | Wright, Jr. | Apr 2005 | A1 |
20050090890 | Wu et al. | Apr 2005 | A1 |
20050267555 | Marnfeldt et al. | Dec 2005 | A1 |
20060247753 | Wenger et al. | Nov 2006 | A1 |
20070135883 | Drasler et al. | Jun 2007 | A1 |
20070150037 | Hastings et al. | Jun 2007 | A1 |
20070150038 | Hastings et al. | Jun 2007 | A1 |
20070233218 | Kolberg | Oct 2007 | A1 |
20070239248 | Hastings et al. | Oct 2007 | A1 |
20070255376 | Michels et al. | Nov 2007 | A1 |
20070276444 | Gelbart | Nov 2007 | A1 |
20070293904 | Gelbart | Dec 2007 | A1 |
20080021532 | Kveen et al. | Jan 2008 | A1 |
20090082828 | Ostroff | Mar 2009 | A1 |
20090143853 | Morris | Jun 2009 | A1 |
20090281605 | Marnfeldt et al. | Nov 2009 | A1 |
20100198288 | Ostroff | Aug 2010 | A1 |
20110034939 | Kveen et al. | Feb 2011 | A1 |
20110112548 | Fifer et al. | May 2011 | A1 |
20110125163 | Rutten et al. | May 2011 | A1 |
20110190785 | Gerber et al. | Aug 2011 | A1 |
20110190786 | Gerber et al. | Aug 2011 | A1 |
20110208260 | Jacobson | Aug 2011 | A1 |
20110237967 | Moore et al. | Sep 2011 | A1 |
20110270339 | Murray, III et al. | Nov 2011 | A1 |
20110270340 | Pellegrini et al. | Nov 2011 | A1 |
20110282423 | Jacobson | Nov 2011 | A1 |
20110307043 | Ollivier | Dec 2011 | A1 |
20120078322 | Dal Molin et al. | Mar 2012 | A1 |
20120078336 | Helland | Mar 2012 | A1 |
20120095539 | Khairkhahan et al. | Apr 2012 | A1 |
20120109002 | Mothilal et al. | May 2012 | A1 |
20120109079 | Asleson et al. | May 2012 | A1 |
20120109148 | Bonner et al. | May 2012 | A1 |
20120109149 | Bonner et al. | May 2012 | A1 |
20120116489 | Khairkhahan et al. | May 2012 | A1 |
20120158111 | Khairkhahan et al. | Jun 2012 | A1 |
20120165827 | Khairkhahan et al. | Jun 2012 | A1 |
20120172690 | Anderson et al. | Jul 2012 | A1 |
20120172891 | Lee | Jul 2012 | A1 |
20120172892 | Grubac et al. | Jul 2012 | A1 |
20120197373 | Khairkhahan et al. | Aug 2012 | A1 |
20120232565 | Kveen et al. | Sep 2012 | A1 |
20120271134 | Allan et al. | Oct 2012 | A1 |
20120330392 | Regnier et al. | Dec 2012 | A1 |
20130006261 | Lampropoulos et al. | Jan 2013 | A1 |
20130006262 | Lampropoulos et al. | Jan 2013 | A1 |
20130012925 | Berthiaume | Jan 2013 | A1 |
20130035636 | Beasley et al. | Feb 2013 | A1 |
20130035748 | Bonner et al. | Feb 2013 | A1 |
20130053921 | Bonner et al. | Feb 2013 | A1 |
20130079798 | Tran et al. | Mar 2013 | A1 |
20130079861 | Reinert et al. | Mar 2013 | A1 |
20130103047 | Steingisser et al. | Apr 2013 | A1 |
20130103049 | Medtronic | Apr 2013 | A1 |
20130116741 | Bornzin et al. | May 2013 | A1 |
20130123875 | Varady et al. | May 2013 | A1 |
20130131591 | Berthiaume et al. | May 2013 | A1 |
20130131693 | Berthiaume et al. | May 2013 | A1 |
20130253342 | Griswold et al. | Sep 2013 | A1 |
20130253343 | Waldhauser et al. | Sep 2013 | A1 |
20130253344 | Griswold et al. | Sep 2013 | A1 |
20130253345 | Griswold et al. | Sep 2013 | A1 |
20130253346 | Griswold et al. | Sep 2013 | A1 |
20130253347 | Griswold et al. | Sep 2013 | A1 |
20130296957 | Tronnes | Nov 2013 | A1 |
20140058494 | Ostroff et al. | Feb 2014 | A1 |
20140074114 | Khairkhahan et al. | Mar 2014 | A1 |
20140148815 | Wenzel et al. | May 2014 | A1 |
20140180306 | Grubac et al. | Jun 2014 | A1 |
Number | Date | Country |
---|---|---|
1003904 | Jan 1977 | CA |
2053919 | May 1972 | DE |
779080 | May 2003 | EP |
05245215 | Sep 1993 | JP |
03032807 | Apr 2003 | WO |
2009039400 | Mar 2009 | WO |
2012092067 | Jul 2012 | WO |
2012092074 | Jul 2012 | WO |
Entry |
---|
Spickler, et al. “Totally Self-Contained Intracardiac Pacemaker” J. Electrocardiology, vol. 3, Nos. 3 & 4, pp. 325-331 (1970). |
Number | Date | Country | |
---|---|---|---|
20150051613 A1 | Feb 2015 | US |
Number | Date | Country | |
---|---|---|---|
61866898 | Aug 2013 | US |